JP2018529666A5 - - Google Patents

Download PDF

Info

Publication number
JP2018529666A5
JP2018529666A5 JP2018511381A JP2018511381A JP2018529666A5 JP 2018529666 A5 JP2018529666 A5 JP 2018529666A5 JP 2018511381 A JP2018511381 A JP 2018511381A JP 2018511381 A JP2018511381 A JP 2018511381A JP 2018529666 A5 JP2018529666 A5 JP 2018529666A5
Authority
JP
Japan
Prior art keywords
composition
hydroxyacetoxy
cyclopentyl
carboxymethyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018511381A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018529666A (ja
JP6750900B2 (ja
Filing date
Publication date
Priority claimed from US14/845,645 external-priority patent/US10632067B2/en
Application filed filed Critical
Publication of JP2018529666A publication Critical patent/JP2018529666A/ja
Publication of JP2018529666A5 publication Critical patent/JP2018529666A5/ja
Priority to JP2020134413A priority Critical patent/JP6981694B2/ja
Application granted granted Critical
Publication of JP6750900B2 publication Critical patent/JP6750900B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018511381A 2014-03-13 2016-08-26 選択された抗コリン作用性双性イオンの使用 Expired - Fee Related JP6750900B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020134413A JP6981694B2 (ja) 2014-03-13 2020-08-07 選択された抗コリン作用性双性イオンの使用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461952342P 2014-03-13 2014-03-13
US14/845,645 2015-09-04
US14/845,645 US10632067B2 (en) 2014-03-13 2015-09-04 Use of selected anticholinergic zwitterions
PCT/US2016/049047 WO2017040307A1 (en) 2014-03-13 2016-08-26 Use of selected anticholinergic zwitterions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020134413A Division JP6981694B2 (ja) 2014-03-13 2020-08-07 選択された抗コリン作用性双性イオンの使用

Publications (3)

Publication Number Publication Date
JP2018529666A JP2018529666A (ja) 2018-10-11
JP2018529666A5 true JP2018529666A5 (enExample) 2019-10-03
JP6750900B2 JP6750900B2 (ja) 2020-09-02

Family

ID=54072392

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016556253A Withdrawn JP2017507959A (ja) 2014-03-13 2015-03-12 選択された抗コリン作動性両性イオンの使用
JP2018511381A Expired - Fee Related JP6750900B2 (ja) 2014-03-13 2016-08-26 選択された抗コリン作用性双性イオンの使用
JP2020050858A Expired - Fee Related JP6732356B2 (ja) 2014-03-13 2020-03-23 選択された抗コリン作動性両性イオンの使用
JP2020115416A Expired - Fee Related JP6968457B2 (ja) 2014-03-13 2020-07-03 選択された抗コリン作動性両性イオンの使用
JP2020134413A Expired - Fee Related JP6981694B2 (ja) 2014-03-13 2020-08-07 選択された抗コリン作用性双性イオンの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016556253A Withdrawn JP2017507959A (ja) 2014-03-13 2015-03-12 選択された抗コリン作動性両性イオンの使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2020050858A Expired - Fee Related JP6732356B2 (ja) 2014-03-13 2020-03-23 選択された抗コリン作動性両性イオンの使用
JP2020115416A Expired - Fee Related JP6968457B2 (ja) 2014-03-13 2020-07-03 選択された抗コリン作動性両性イオンの使用
JP2020134413A Expired - Fee Related JP6981694B2 (ja) 2014-03-13 2020-08-07 選択された抗コリン作用性双性イオンの使用

Country Status (3)

Country Link
US (2) US10632067B2 (enExample)
JP (5) JP2017507959A (enExample)
WO (2) WO2015138700A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
WO2015138700A1 (en) 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions
HK1253236A1 (zh) 2015-07-21 2019-06-14 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
WO2018006001A1 (en) * 2016-07-01 2018-01-04 Bodor Laboratories, Inc. Compositions and methods for treatment of copd
TWI719046B (zh) * 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
CA3182431A1 (en) * 2020-06-11 2021-12-16 Andrei V. Tkatchenko Methods and compositions for preventing and treating myopia with fingolimod, a sphingosine-1-phosphate receptor modulator, and derivatives thereof
KR20230051153A (ko) * 2020-06-11 2023-04-17 더 트러스티스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 히스톤 데아세틸레이스(hdac) 저해제인 트라이코스타틴 a 및 이의 유도체를 이용한 근시의 예방 및 치료를 위한 방법 및 조성물
IL298974A (en) * 2020-06-11 2023-02-01 Univ Columbia METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH FENOTEROL HYDROBROMIDE, A β2- ADRENERGIC RECEPTOR AGONIST, AND DERIVATIVES THEREOF
CN115966912B (zh) * 2023-01-09 2025-08-22 西安电子科技大学 一种2比特高功率放大型非互易反射式超表面

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU701127B2 (en) * 1994-10-27 1999-01-21 Merck & Co., Inc. Muscarine antagonists
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
CA2461696A1 (en) 2001-09-26 2003-04-03 Alison B. Lukacsko Compositions and methods for inhibiting eccrine perspiration in humans
ATE529399T1 (de) 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
EP1957451B1 (en) * 2005-11-10 2011-10-19 Nicholas S. Bodor Soft anticholinergic zwitterions
JP2007308398A (ja) * 2006-05-17 2007-11-29 Chang Gung Memorial Hospital 目薬、及びその製造方法
CA2674076A1 (en) * 2006-12-26 2008-07-10 Qlt Plug Delivery, Inc. Drug delivery implants for inhibition of optical defects
US8618160B2 (en) 2007-10-18 2013-12-31 Rose U Topical glycopyrrolate formulations
JP6223543B2 (ja) 2013-03-15 2017-11-01 ボドール ラボラトリーズ， インコーポレイテッド 多汗症の処置のための抗コリン作用性グリコピロレートエステル
WO2015138700A1 (en) 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions

Similar Documents

Publication Publication Date Title
MX393855B (es) Terapia de combinación que comprende un inhibidor de raf y trametinib
MX2021002321A (es) Nuevos metodos.
MX2021004431A (es) Procesos novedosos.
JP2018111728A5 (enExample)
JP2016147915A5 (enExample)
RU2018110647A (ru) Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний
JP2016540785A5 (enExample)
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
WO2014144130A3 (en) Pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of use thereof
JP2016535795A5 (enExample)
JP2017506624A5 (enExample)
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
CN110114083A (zh) 一种预防和治疗脂肪肝的方法
JP2017214429A5 (enExample)
EA201492010A1 (ru) Применение высокой дозы лахинимода для лечения рассеянного склероза
FI3307271T3 (fi) Pyruvaattikinaasin aktivaattorien käyttämisen menetelmä
MX383665B (es) Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer.
JP2015505564A5 (enExample)
JP2017503014A5 (enExample)
CA2986891C (en) Compositions for use in treating parkinson's disease and related disorders
JP2018530578A5 (enExample)
CN109689652A (zh) 稠杂环类衍生物、其制备方法及其在医学上的应用
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
JP2016515550A5 (enExample)
EA201792237A1 (ru) Фармацевтические составы